E-LIB Suche - Ergebnisse für: Horwitz, S.

1

Long term outcome of Peripheral T Cell Lymphomas: 10y follo..:

Civallero, M. ; Advani, R. ; Horwitz, S....
Hematological Oncology. 41 (2023) S2 - p. 491-492 , 2023

Link: https://doi.org/10.1002/..

2

PHASE 2 TRIAL OF NIVOLUMAB PLUS ADRIAMYCIN, VINBLASTINE, DA..:

Torka, P. ; Feldman, T. ; Savage, K....
Hematological Oncology. 41 (2023) S2 - p. 161-162 , 2023

Link: https://doi.org/10.1002/..

3

AFM13 IN PATIENTS WITH CD30 POSITIVE RELAPSED OR REFRACTORY..:

Kim, W. S. ; Shortt, J. ; Zinzani, P. L....
Hematological Oncology. 41 (2023) S2 - p. 195-196 , 2023

Link: https://doi.org/10.1002/..

4

Mature T and NK cell lymphomas classified according to 2016..:

Manni, M. ; Chiattone, C. S. ; Prince, M. H....
Hematological Oncology. 41 (2023) S2 - p. 311-312 , 2023

Link: https://doi.org/10.1002/..

5

BRCA1/2 MUTATIONS IMPACT ON THE DEVELOPMENT OF BREAST IMPLA..:

Ghione, P. ; Arcila, M. ; Joseph, V....
Hematological Oncology. 41 (2023) S2 - p. 193-194 , 2023

Link: https://doi.org/10.1002/..

6

PET‐Adapted Therapy with Nivolumab plus Adriamycin, Vinblas..:

Moskowitz, A. ; Savage, K. ; Feldman, T....
Hematological Oncology. 41 (2023) S2 - p. 351-353 , 2023

Link: https://doi.org/10.1002/..

7

PB2121: EFFECT OF EDUCATIONAL ACTIVITY ON THE KNOWLEDGE OF ..:

Harvey-Jones, V. ; Koekkoek, S. ; Dorkhom, N..
HemaSphere. 6 (2022) - p. 1992-1993 , 2022

Link: https://doi.org/10.1097/..

8

The ECHELON-2 Trial: 5-year results of a randomized, phase ..:

Horwitz, S. ; O'Connor, O.A. ; Pro, B....
Annals of Oncology. 33 (2022) 3 - p. 288-298 , 2022

Link: https://doi.org/10.1016/..

9

A PHASE II TRIAL OF REDUCED DOSE BRENTUXIMAB VEDOTIN FOR CU..:

Khan, N. ; Noor, S. ; Geller, S....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

10

PRELIMINARY ACTIVITY OF DEVIMISTAT (CPI 613) IN PATIENTS WI..:

Nikolaenko, L. ; Pardee, T. S. ; Steiner, R....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

11

FIRST‐IN‐HUMAN STUDY OF THE EZH1 AND EZH2 DUAL INHIBITOR VA..:

Ishitsuka, K ; Izutsu, K ; Maruyama, D...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

12

High Local Control And Overall Survival With Radiotherapy F..:

Wijetunga, N.A.A. ; Lee, J. ; Imber, B.S....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e759 , 2020

Link: https://doi.org/10.1016/..

13

A PHASE 1/1B DOSE‐ESCALATION TRIAL EVALUATING CPI‐818, AN O..:

Mobasher, M. ; Miller, R. ; Janc, J....
Hematological Oncology. 37 (2019) S2 - p. 563-564 , 2019

Link: https://doi.org/10.1002/..

14

CLINICAL CHARACTERISTICS AND OUTCOMES OF STAGE I DIFFUSE LA..:

Bobillo, S. ; Joffe, E. ; Lavery, J....
Hematological Oncology. 37 (2019) S2 - p. 251-252 , 2019

Link: https://doi.org/10.1002/..

15

PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THER..:

Lunning, M. ; Horwitz, S. ; Advani, R....
Hematological Oncology. 37 (2019) S2 - p. 280-281 , 2019

Link: https://doi.org/10.1002/..